Effect of Broad Spectrum Antimicrobial Agents Use Monitoring Policy on Drug Resistance in Pseudomonas aeruginosa

  • SOEDA Hiroshi
    Department of Pharmacy, Tokyo Medical University Hospital Department of Infection Control and Prevention, Tokyo Medical University Hospital
  • KANEKO Akiko
    Department of Pharmacy, Tokyo Medical University Hospital Department of Infection Control and Prevention, Tokyo Medical University Hospital
  • INUBUSE Atsuo
    Department of Pharmacy, Tokyo Medical University Hospital
  • AKASHI Takao
    Department of Pharmacy, Tokyo Medical University Hospital
  • CHIBA Katsumi
    Department of Clinical Laboratory, Tokyo Medical University Hospital Department of Infection Control and Prevention, Tokyo Medical University Hospital
  • SATOH Kumi
    Department of Infection Control and Prevention, Tokyo Medical University Hospital
  • KUSAMA Yumiko
    Department of Infection Control and Prevention, Tokyo Medical University Hospital
  • NAKAMURA Itaru
    Department of Infection Control and Prevention, Tokyo Medical University Hospital
  • MATSUNAGA Naohisa
    Department of Infection Control and Prevention, Tokyo Medical University Hospital
  • KOSHIHARA Kimihito
    Department of Infection Control and Prevention, Tokyo Medical University Hospital
  • MATSUMOTO Tetsuya
    Department of Infection Control and Prevention, Tokyo Medical University Hospital

Bibliographic Information

Other Title
  • 広域抗菌薬使用への使用調査制による介入が緑膿菌の抗菌薬感受性に及ぼす効果
  • コウイキ コウキンヤク シヨウ エ ノ シヨウ チョウサセイ ニ ヨル カイニュウ ガ リョクノウキン ノ コウキンヤク カンジュセイ ニ オヨボス コウカ

Search this article

Abstract

  Overuse of antimicrobial agents may lead to increased drug resistance in various strains of bacteria. Our institution started a use monitoring policy for broad spectrum antimicrobial agents. In this study, Antimicrobial use density (AUD) of carbapenem (CBPM) and fluoroquinolone (FQ) antimicrobial agents for every half year between April 1, 2007 and March 31, 2009 and the trends of resistance to IPM/CS and CPFX of Pseudomonas aeruginosa were analyzed to evaluate the use monitoring policy. The resistance rates to IPM/CS and CPFX were decreased from 29% and 20% to 21% and 15%, respectively. Mean administration days and long-term administration rates of CBPM were decreased from 7 days and 32% to 6 days and 24%, respectively, and the AUD of CBPM showed slightly decreasing trends. In contrast, the AUD of FQ showed little change. The present study indicates that the use monitoring policy was effective for reducing carbapenem antimicrobial agent use, and reduces the antimicrobial resistance of P. aeruginosa.<br>

Journal

Citations (2)*help

See more

References(10)*help

See more

Details 詳細情報について

Report a problem

Back to top